Medical release archive
Here you can find the archive of all Medical releases prior to 2022
Filter by date:
Showing 102 medical releases before 2023
-
New tezepelumab data show 86% reduction in exacerbations in patients with severe asthma and comorbid nasal polyps
-
New data at ESC Congress 2021 showcase AstraZeneca’s leading cardiovascular, renal and metabolic portfolio
-
Bydureon BCise (exenatide extended-release) approved in the US for the treatment of type-2 diabetes in paediatric patients ages 10 years and older
-
AstraZeneca’s investigational MPO inhibitor AZD4831 shows promise in patients with heart failure and a preserved ejection fraction
-
New data at Heart Failure 2021 showcases AstraZeneca’s leading and diverse heart failure portfolio
-
New Fasenra data from the MELTEMI extension trial confirm long-term safety and efficacy in severe eosinophilic asthma for up to five years
-
New tezepelumab data continue to strengthen profile for a broad population of severe asthma patients
-
First patients dosed in three dermatology trials evaluating Fasenra in bullous pemphigoid, atopic dermatitis and chronic spontaneous urticaria
-
New data show overuse of reliever medication in asthma is responsible for 250,000 tonnes of greenhouse gas emissions every year in the UK
-
medical release template
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
